◀ Back to NOS2
NOS2 — TGFB3
Pathways - manually collected, often from reviews:
Text-mined interactions from Literome
Bogdan et al., Immunol Rev 2000
(Leishmaniasis, Cutaneous) :
During the early phase of infection with the intracellular pathogen Leishmania major, focally expressed
NOS2/NO not only exerts antimicrobial activities but also
controls the function of natural killer cells and the expression of cytokines such as IFN-gamma or
transforming growth factor-beta
Saura et al., Circ Res 2002
:
Smad2 mediates
transforming growth factor-beta induction of endothelial
nitric oxide synthase expression
Saed et al., Wound Repair Regen 2009
(Anoxia...) :
Additionally, silencing
iNOS reduced type I collagen and
transforming growth factor-beta in adhesion fibroblasts, but to a lesser extent in peritoneal fibroblasts
Stenger et al., J Exp Med 1994
(Leishmaniasis, Cutaneous) :
In the lesions of BALB/c mice, cells staining positively for
transforming growth factor beta ( TGF-beta ), a potent
inhibitor of
iNOS in vitro, were strikingly more prominent than in C57BL/6, whereas no such difference was found for interleukin 4 or interferon gamma (IFN-gamma)
Goureau et al., Proc Natl Acad Sci U S A 1993
:
Differential
regulation of inducible
nitric oxide synthase by fibroblast growth factors and
transforming growth factor beta in bovine retinal pigmented epithelial cells : inverse correlation with cellular proliferation
Vincent et al., Glia 1997
:
Inhibition of endotoxin induced
nitric oxide synthase production in microglial cells by the presence of astroglial cells : a
role for
transforming growth factor beta